Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Seelos Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q4 2023
- Shares held
- 2.63M
- +842.5K (+47.2%) vs. Q4 2023
- Total value
- $1.55M
- −$927.8K (−37.4%) vs. Q4 2023
- New holders
- 6
- 12 more added
- Sold out
- 9
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SEEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 3 | $4.77K |
| Q3 2024 | 15 | $145.2K |
| Q2 2024 | 23 | $129.4K |
| Q1 2024 | 36 | $1.55M |
| Q4 2023 | 39 | $2.48M |
| Q3 2023 | 82 | $7.01M |
| Q2 2023 | 83 | $27.1M |
| Q1 2023 | 80 | $15.1M |
| Q4 2022 | 80 | $15.6M |
| Q3 2022 | 85 | $28.0M |
| Q2 2022 | 86 | $21.3M |
| Q1 2022 | 92 | $33.0M |
| Q4 2021 | 97 | $65.9M |
| Q3 2021 | 110 | $98.2M |
| Q2 2021 | 105 | $107.8M |
| Q1 2021 | 73 | $124.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Seelos Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wealth Effects LLC | 466,660 | $275.8K | 0.10% | +238,067+104.1% | Added |
| AdvisorShares Investments LLC | 462,694 | $273.5K | 0.05% | +281,435+155.3% | Added |
| Gendell Jeffrey L | 428,966 | $253.5K | 0.01% | +317,351+284.3% | Added |
| Balyasny Asset Management LLC | 379,239 | $224.1K | 0.00% | +114,485+43.2% | Added |
| Vanguard Group Inc | 280,866 | $166.0K | 0.00% | −3,012−1.1% | Reduced |
| Modera Wealth Management, LLC | 157,617 | $93.2K | 0.00% | +87,889+126.0% | Added |
| Morgan Stanley | 126,064 | $74.5K | 0.00% | +55,901+79.7% | Added |
| Geode Capital Management, LLC | 102,408 | $60.5K | 0.00% | +73,065+249.0% | Added |
| BlackRock Inc. | 55,961 | $33.1K | 0.00% | −30.0% | Reduced |
| Strategic Family Wealth Counselors, L.L.C. | 30,010 | $17.7K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 23,009 | $13.6K | 0.00% | +23,009 | New |
| XTX Topco Ltd | 16,071 | $9.50K | 0.00% | +16,071 | New |
| Two Sigma Investments, LP | 13,085 | $7.73K | 0.00% | −12,161−48.2% | Reduced |
| State Street Corp | 12,948 | $7.65K | 0.00% | 00.0% | Unchanged |
| CRA Financial Services, LLC | 11,889 | $7.03K | 0.00% | +11,889 | New |
| Tower Research Capital LLC (TRC) | 10,517 | $6.22K | 0.00% | +5,237+99.2% | Added |
| UBS Group AG | 10,166 | $6.01K | 0.00% | +9,759+2,397.8% | Added |
| Wealth Enhancement Advisory Services, LLC | 10,018 | $5.92K | 0.00% | +10,018 | New |
| Advisor Group Holdings, Inc. | 8,233 | $4.76K | 0.00% | −513−5.9% | Reduced |
| Carmichael Hill & Associates, Inc. | 8,000 | $4.73K | 0.00% | +3,000+60.0% | Added |
| JPMorgan Chase & Co | 4,032 | $2.38K | 0.00% | +2,017+100.1% | Added |
| Bank of America Corp | 3,757 | $2.22K | 0.00% | −10.0% | Reduced |
| Group One Trading, L.P. | 1,824 | $1.08K | 0.00% | −7,247−79.9% | Reduced |
| Vermillion & White Wealth Management Group, LLC | 996 | $588 | 0.00% | +996 | New |
| Crewe Advisors LLC | 925 | $547 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 440 | $260 | 0.00% | +69+18.6% | Added |
| First Manhattan Co | 372 | $219 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 199 | $118 | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 86 | $51 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 50 | $30 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 33 | $19 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 28 | $17 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 33 | $9 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 12 | $8 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $2 | 0.00% | +3 | New |
| TSFG, LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −303,714−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −40,536−100.0% | Sold out |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| LM Advisors LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |